shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

    PAR-24-029

    National Institutes of Health

    Opening date 14 Aug 2023, 12:00AM

    Closing date 4 Dec 2026, 12:00AM

    Funding Opportunity Number: PAR-24-029

    Opportunity Category: Discretionary

    CFDA Number(s): 93.855 -- Allergy and Infectious Diseases Research

    Cost Sharing or Matching Requirement: No

    Posted Date: Aug 14, 2023 12:00:00 AM EDT

    Closing Date: Dec 04, 2026 12:00:00 AM EST

    Award Ceiling: $225000

    Award Floor: none

    Eligible Applicants: Public housing authorities/Indian housing authorities,Public and State controlled institutions of higher education,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Others (see text field entitled "Additional Information on Eligibility" for clarification),Private institutions of higher education,City or township governments,State governments,Native American tribal organizations (other than Federally recognized tribal governments),Independent school districts,Small businesses,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,County governments,For profit organizations other than small businesses,Special district governments,Native American tribal governments (Federally recognized)

    Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

    Agency Name: National Institutes of Health

    Description: The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.

    Grantor Contact Information: NIH Grants Information grantsinfo@nih.gov

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept